Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Diseases

Free Subscription Articles published in Cancer Retrieve available abstracts of 20 articles: HTML format

Single Articles

September 2025
1. JUDGE SJ, Manin E, Chou J, Torphy RJ, et al
   Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma.
   Cancer. 2025;131:e70088.
   PubMed     Abstract available
   
   
   February 2025
2. KUEHNLE RA, Tchelebi LT, Ludmir EB, Escorcia FE, et al
   Meta-analysis of randomized controlled trials of external-beam radiation versus transarterial chemoembolization for hepatocellular carcinoma.
   Cancer. 2025;131:e35720.
   PubMed     Abstract available
   
   
   January 2025
3. NIERENGARTEN MB
   Potential new treatment approach for intermediate-stage hepatocellular carcinoma.
   Cancer. 2025;131:e35687.
   PubMed    
   
   
   November 2024
4. IHEANACHO F, Tramontano AC, Abrams TA, Manz CR, et al
   Changing treatment patterns for hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results-Medicare study.
   Cancer. 2024 Nov 12. doi: 10.1002/cncr.35649.
   PubMed     Abstract available
   
   
   October 2024
5. ZAMANI SA, Graubard BI, Hyer M, Carver E, et al
   Use of cholesterol-lowering medications in relation to risk of primary liver cancer in the Clinical Practice Research Datalink.
   Cancer. 2024;130:3506-3518.
   PubMed     Abstract available
   
   
   September 2024
6. TSAI FP, Su TH, Huang SC, Tseng TC, et al
   Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease.
   Cancer. 2024 Sep 6. doi: 10.1002/cncr.35541.
   PubMed     Abstract available
   
   
   August 2024
7. KANTARJIAN HM, Boissel N, Papayannidis C, Luskin MR, et al
   Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions.
   Cancer. 2024 Aug 2. doi: 10.1002/cncr.35505.
   PubMed     Abstract available
   
   
   
8. VAN NOESEL MM
   Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver.
   Cancer. 2024;130:2582-2585.
   PubMed    
   
   
   
9. AWAD A, Pal K, Yevich S, Kuban JD, et al
   Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver.
   Cancer. 2024;130:2703-2712.
   PubMed     Abstract available
   
   
   
10. SPUNT SL, Xue W, Gao Z, Hayes Dixon A, et al
    Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332.
    Cancer. 2024;130:2683-2693.
    PubMed     Abstract available
    
    
    May 2024
11. NING T, Li D, Deng T, Bai Y, et al
    Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study.
    Cancer. 2024 May 23. doi: 10.1002/cncr.35377.
    PubMed     Abstract available
    
    
    
12. NIERENGARTEN MB
    Global phase 3 results show that bevacizumab with immunotherapy has activity in liver cancer.
    Cancer. 2024;130:1547-1548.
    PubMed    
    
    
    February 2024
13. CONNOLLY GK, Harris RD, Shumate C, Rednam SP, et al
    Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children.
    Cancer. 2024;130:467-475.
    PubMed     Abstract available
    
    
    January 2024
14. PORTA C, Negri F, Cosmai L
    Hepatocellular carcinoma, vascular endothelial growth factor receptors-targeting agents, and hypertension: A much more complicated relationship than expected.
    Cancer. 2024 Jan 27. doi: 10.1002/cncr.35218.
    PubMed    
    
    
    
15. PISCAGLIA F, Ikeda K, Cheng AL, Kudo M, et al
    Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
    Cancer. 2024 Jan 23. doi: 10.1002/cncr.35185.
    PubMed     Abstract available
    
    
    
16. COLLOCA GA, Venturino A
    Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial-level analysis.
    Cancer. 2024 Jan 17. doi: 10.1002/cncr.35199.
    PubMed     Abstract available
    
    
    November 2023
17. ACUNA N, Zhou K, Pinheiro PS, Cheng I, et al
    Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort.
    Cancer. 2023 Nov 20. doi: 10.1002/cncr.35000.
    PubMed     Abstract available
    
    
    
18. WONG EC, Lupo PJ, Desrosiers TA, Nichols HB, et al
    Associations between birth defects with neural crest cell origins and pediatric embryonal tumors.
    Cancer. 2023;129:3595-3602.
    PubMed     Abstract available
    
    
    
19. 
    Erratum to "Association between posttreatment alpha-fetoprotein reduction and outcomes in real-world US patients with advanced hepatocellular carcinoma".
    Cancer. 2023 Nov 4. doi: 10.1002/cncr.35102.
    PubMed    
    
    
    October 2023
20. HALLEMEIER CL, Sharma N, Anker C, Selfridge JE, et al
    American Radium Society Appropriate Use Criteria for the use of liver-directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines.
    Cancer. 2023;129:3193-3212.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.